Adults, 19 through 50 years
AIs, 21
derivation of DRIs for, 21, 32
EARs, 8–9
extrapolation of data to other age groups, 31–33, 66
supplement use, 272
Adults, 51 through 70 years
AIs, 21
ULs, 48–49
Adults, >70 years
EARs, 8–9
pernicious anemia in, 317, 332–333
supplement use, 18, 79, 81, 113, 182, 273, 346, 462–465
ULs, 48
biotin, 384–385
defined, 41
evidence of, 50–51
folate, 273–277
interindividual variability in sensitivity, 48–49
nutrient-nutrient interactions, 41, 49, 51, 273–274
pantothenic acid, 370
research recommendations, 15, 441–442
source of nutrient and, 47–48
vitamin B12, 346
African Americans. See Blacks
Aging. See also Life-stage groups;
individual life stages
and energy metabolism, 75, 110
and metabolism of nutrients, 213–214, 228–229, 233
and nutrient requirements, 318–320
and nutrient toxicity, 48
and plasma homocysteine, 159, 203, 518–519
Alanine aminotransferase, 157, 390, 394, 395, 403
Alcohol consumption and alcoholism and folate, 204, 211, 240, 263, 266, 268, 276, 525
and vitamin B6, 164
and vitamin B12, 347
Allergic sensitivity, 81–82
American Academy of Pediatrics, 30, 31
Amino acid metabolism, 58, 88, 150, 151, 161, 196, 197, 358.
See also individual amino acids
Aminopterin, 246
Anaphylaxis, 81
Anemia, 90, 153, 200, 201, 233, 234, 267, 329, 334.
See also Pernicious anemia
Aneurin. See Thiamin
Animal studies
choline, 396, 397, 398, 399, 413–414
considerations in use of data from, 53
extrapolation of data from, 28, 43–44, 46, 52, 55, 56, 153
neural tube defects, 244, 245, 523–525
vitamin B12 deficiency, 274, 310, 346
Anticonvulsants, 212, 240, 246, 276, 380, 525
Anti-inflammatory drugs (nonsteroidal), 212
Apotyrosine decarboxylase assay, 156
Arnold Chiari malformation, 241
Asians, pernicious anemia, 317
Aspartate aminotransferase, 157
Aspirin, 212
Atherosclerosis, 260
Atrophic gastritis, 200, 312, 317, 318, 320, 331, 337, 340, 341, 342, 527